sodium tetradecyl sulfate (Sotradecol) Report issue

Small molecule Approved FDA Priority Review FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA PubChem repoDB

Active Ingredient History

NOW
  • Now
Sodium tetradecyl sulfate (STS) is a common anionic surfactant. The compound consists of the sodium salt of the micelle-forming sulfate ester of tetradecanol. It is a white, water-soluble solid of low toxicity with many practical uses.   Wikipedia

Chemistry

  • SMILES: [Na+].CCCCC(CC)CCC(CC(C)C)OS(=O)(=O)[O-]
  • InChIKey: FVEFRICMTUKAML-UHFFFAOYSA-M
  • Mol. Mass: 316.44
  • ALogP: 4.22
  • ChEMBL Molecule:
    sodium tetradecyl sulfate  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$72.8640
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

7-ethyl-2-methyl-4-undecanol sulfate sodium salt | 7-ethyl-2-methyl-4-undecanolsulfate, sodium salt | fibrovein | fibro-vein | natrii tetradecylis sulfa | sodium 2-methyl-7-ethylundecanol-4-sulfate | sodium 7-ethyl-2-methyl-4-undecanol sulfate | sodium tetradecylsulfate | sodium tetradecyl sulfate | sodium tetradecyl sulphate | sotradecol | s.t.d. | sts | tetradecilsulfato sodico | tetradecyl sodium sulfate | tetradecyl sodium sulphate | tetradecyl sulfate de sodium

Organizations (17)

Research & Development (12)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (5)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (7)

Approved Indications (1)


 

Varicose Veins (approved 1946)

Experimental Indications - Clinical Trial Phases 1-4 (7)


 

Cost-Benefit Analysis (Early Phase 1)

Edema (Early Phase 1)

Pain (Early Phase 1)

Prostheses and Implants (Early Phase 1)

Varicose Veins (Phase 4)

Venous Cutdown (Phase 4)

Venous Insufficiency (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial Organizations: 12

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue